framing.co.kr

What It Is

Framing’s SurgeFlow is a Korean AI medical solution positioned as a clinical workflow platform for surgical healthcare professionals. Its goal is to turn ward-round notes, operative records, imaging, and case materials into searchable and analyzable data assets—without adding extra data-entry burden for doctors—while connecting three key stakeholders: physicians, patients, and hospitals.

Core Capabilities

The platform emphasizes “minimal input, maximum automation.” On the physician side, it supports mobile schedule viewing, case entry in about 30 seconds, LLM-powered automatic structuring of operative notes, and surgical pattern reports. For hospitals, it offers automatic archiving of surgical videos, OCR/NLP-based keyword search, and indexing by procedure type and implants. For patients, it provides QR-linked personalized rehabilitation protocols, X-ray-based visual recovery timelines, and phased exercise guidance. Its longer-term roadmap also includes surgery duration prediction, operating room workflow optimization, patient recovery pattern analysis, and prognosis prediction.

Pricing and Business Model

The available materials only state that SurgeFlow uses a B2B SaaS adoption model, initially targeting medical teams in secondary and tertiary hospitals in Korea. Specific pricing, trials, free quotas, deployment options, and payment methods have not been disclosed. As a result, it is currently difficult to assess procurement barriers or total cost of ownership.

Pros and Cons

Its strengths lie in a focused use case: it targets clear pain points such as repetitive documentation for surgeons, scattered clinical materials, and gaps in post-operative follow-up. The product design is relatively complete across the physician, patient, and hospital sides. The company also discloses 2 Korean patents, a PCT application, LOIs from 8 specialist doctors, university hospital collaboration channels, and seed-stage investment interest.

The limitations are that several key capabilities remain on the roadmap, and there is a lack of real customer cases, accuracy metrics, clinical validation results, security/compliance information, and system integration details. Medical AI has high requirements for reliability and clear accountability boundaries; the absence of these details may affect hospitals’ purchasing decisions.

Who It’s For and Access from China

SurgeFlow is worth watching for surgical departments, hospital IT teams, digital health investors, and medical institutions building surgical data assets. Its accessibility from China is unknown; Chinese-language support has not been disclosed, and there is no information on payment or local compliance. If deployed in China, key areas to evaluate would include integration with HIS/EMR/PACS, cross-border data transfer, regulatory requirements for medical device software, and domestic alternatives such as Chinese healthcare IT vendors or clinical data platforms.